Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2025C534 Product name: tisotumab vedotine of een biosimilar ervan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2025C/534
Type:
Certificate
SPC type:
Medical
Basic patent number:
117250951
Status:
Open & Published
Publication number:
2025C534
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/25/1911
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
31/03/2025
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
19/08/2025
First marketing authorization date:
31/03/2025
Grant date:
Activation date:
BE Publication date:
28/08/2025
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
15/06/2036
SPC/SPC Extension Expiration (if granted and all annual fees paid):
Rejection date:
Withdrawal date:

Applicant

Name:
Genmab A/S
Legal Form:
public limited liability company
From:
28/08/2025
Address:
Carl Jacobsens Vej 30, 2500 Valby, Denmark (DK)
To:

Agent

Name:
DE CLERCQ & PARTNERS CV
Legal Form:
From:
20/08/2025
Address:
Ed. Gevaertdreef 10a, 9830, ST MARTENS LATEM, Belgium (BE)
To:

Publication

Bulletin

Bulletin heading:
SPC
Journal edition number:
2025/16
Publication date:
17/10/2025
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates
Filing date Document type Publication Type Document Description Number of pages File Type
19/08/2025 Abstract Product Characteristics Abstract of the characteristics of the product 36 PDF /3/7/4/2/7/0722572473/docs/2025c534_0_abstractproductcharacteristics_20250820_084548604.pdf
19/08/2025 General Document Other 5 PDF /3/7/4/2/7/0722572473/docs/2025c534_1_generaldocument_20250820_084547751.pdf
19/08/2025 General Document Other 2 PDF /3/7/4/2/7/0722572473/docs/2025c534_2_generaldocument_20250820_084548054.pdf
19/08/2025 General Document Other 4 PDF /3/7/4/2/7/0722572473/docs/2025c534_3_generaldocument_20250820_084547928.pdf
19/08/2025 General Document Other 110 PDF /3/7/4/2/7/0722572473/docs/2025c534_4_generaldocument_20250820_084550229.pdf
19/08/2025 MA Official Publication Official Publication of 1st Marketing Authorization 10 PDF /3/7/4/2/7/0722572473/docs/2025c534_5_maofficialpublication_20250820_084548931.pdf
19/08/2025 Application Form 4 PDF /3/7/4/2/7/0722572473/docs/2025c534_6_applicationform_20250820_084550574.pdf
19/08/2025 Marketing Authorization 1st Marketing Authorization (MS) 3 PDF /3/7/4/2/7/0722572473/docs/2025c534_7_marketingauthorization_20250820_084548228.pdf
07/08/2025 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /3/7/4/2/7/0722572473/docs/2025c534_8_rfc_20250915_113619697.pdf
07/08/2025 Request For Change Letter of regularisation of a change 1 PDF /3/7/4/2/7/0722572473/docs/2025c534_9_rfc_20250915_114250739.pdf
15/09/2025 Outgoing Correspondence Outgoing Correspondence 1 PDF /3/7/4/2/7/0722572473/docs/2025c534_10_221547_pie.rfc.man.notif.pdf